EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 66 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $317,785 | -54.6% | 36,527 | +7.8% | 0.00% | -100.0% |
| Q1 2024 | $700,445 | +177.1% | 33,887 | +209.8% | 0.00% | – |
| Q4 2023 | $252,754 | +194.5% | 10,937 | +1.8% | 0.00% | – |
| Q3 2023 | $85,829 | -8.2% | 10,742 | 0.0% | 0.00% | – |
| Q2 2023 | $93,455 | +209.9% | 10,742 | +4.7% | 0.00% | – |
| Q1 2023 | $30,159 | -16.0% | 10,258 | 0.0% | 0.00% | – |
| Q4 2022 | $35,903 | -55.8% | 10,258 | 0.0% | 0.00% | – |
| Q3 2022 | $81,141 | +0.2% | 10,258 | 0.0% | 0.00% | – |
| Q2 2022 | $81,000 | -67.3% | 10,258 | -56.9% | 0.00% | – |
| Q3 2021 | $248,000 | +18.1% | 23,810 | +1.9% | 0.00% | – |
| Q2 2021 | $210,000 | – | 23,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $42,580,000 | 6.66% |
| Stonepine Capital Management, LLC | 329,130 | $3,344,000 | 1.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 300,000 | $3,048,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 381,145 | $3,872,000 | 1.40% |
| Samsara BioCapital, LLC | 450,000 | $4,572,000 | 0.84% |
| Altium Capital Management LP | 289,316 | $2,939,000 | 0.82% |
| VR Adviser, LLC | 700,000 | $7,112,000 | 0.77% |
| Corriente Advisors, LLC | 200,000 | $2,032,000 | 0.75% |
| RA Capital Management | 1,250,000 | $12,700,000 | 0.19% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,181,200 | $12,001,000 | 0.18% |